244 related articles for article (PubMed ID: 29267192)
1. l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug.
Chiechio S; Canonico PL; Grilli M
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267192
[TBL] [Abstract][Full Text] [Related]
2. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.
Nasca C; Xenos D; Barone Y; Caruso A; Scaccianoce S; Matrisciano F; Battaglia G; Mathé AA; Pittaluga A; Lionetto L; Simmaco M; Nicoletti F
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4804-9. PubMed ID: 23382250
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.
Bigio B; Mathé AA; Sousa VC; Zelli D; Svenningsson P; McEwen BS; Nasca C
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7906-11. PubMed ID: 27354525
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine.
Chiechio S; Copani A; De Petris L; Morales ME; Nicoletti F; Gereau RW
Mol Pain; 2006 Jun; 2():20. PubMed ID: 16764720
[TBL] [Abstract][Full Text] [Related]
5. Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.
Notartomaso S; Mascio G; Bernabucci M; Zappulla C; Scarselli P; Cannella M; Imbriglio T; Gradini R; Battaglia G; Bruno V; Nicoletti F
Mol Pain; 2017 Jan; 13():1744806917697009. PubMed ID: 28326943
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine.
Cuccurazzu B; Bortolotto V; Valente MM; Ubezio F; Koverech A; Canonico PL; Grilli M
Neuropsychopharmacology; 2013 Oct; 38(11):2220-30. PubMed ID: 23670591
[TBL] [Abstract][Full Text] [Related]
7. L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine.
Bersani G; Meco G; Denaro A; Liberati D; Colletti C; Nicolai R; Bersani FS; Koverech A
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1219-25. PubMed ID: 23428336
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine in chronic pain: A narrative review.
Sarzi-Puttini P; Giorgi V; Di Lascio S; Fornasari D
Pharmacol Res; 2021 Nov; 173():105874. PubMed ID: 34500063
[TBL] [Abstract][Full Text] [Related]
9. L-Acetylcarnitine as a histone acetylation modulator in psychiatric disorders.
Peedicayil J
Psychopharmacology (Berl); 2018 Nov; 235(11):3361-3362. PubMed ID: 30251161
[No Abstract] [Full Text] [Related]
10. NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity.
Bortolotto V; Cuccurazzu B; Canonico PL; Grilli M
Biomed Res Int; 2014; 2014():612798. PubMed ID: 24678511
[TBL] [Abstract][Full Text] [Related]
11. Unravelling the efficacy of antidepressants as analgesics.
Janakiraman R; Hamilton L; Wan A
Aust Fam Physician; 2016 Mar; 45(3):113-7. PubMed ID: 27052046
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant drugs and cytokines in mood disorders.
Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
[TBL] [Abstract][Full Text] [Related]
13. Rapid-acting antidepressant-like effects of acetyl-l-carnitine mediated by PI3K/AKT/BDNF/VGF signaling pathway in mice.
Wang W; Lu Y; Xue Z; Li C; Wang C; Zhao X; Zhang J; Wei X; Chen X; Cui W; Wang Q; Zhou W
Neuroscience; 2015 Jan; 285():281-91. PubMed ID: 25463525
[TBL] [Abstract][Full Text] [Related]
14. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
Jobe PC
Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
[TBL] [Abstract][Full Text] [Related]
15. Animal models of depression and neuroplasticity: assessing drug action in relation to behavior and neurogenesis.
Xu Y; Barish PA; Pan J; Ogle WO; O'Donnell JM
Methods Mol Biol; 2012; 829():103-24. PubMed ID: 22231809
[TBL] [Abstract][Full Text] [Related]
16. [The approaches in the discovery of antidepressants using affective disorder models].
Saitoh A; Yamaguchi K; Murasawa H; Kamei J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):75-82. PubMed ID: 12762219
[TBL] [Abstract][Full Text] [Related]
17. Stress-induced structural plasticity of medial amygdala stellate neurons and rapid prevention by a candidate antidepressant.
Lau T; Bigio B; Zelli D; McEwen BS; Nasca C
Mol Psychiatry; 2017 Feb; 22(2):227-234. PubMed ID: 27240534
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain.
Smith MD; Woodhead JH; Handy LJ; Pruess TH; Vanegas F; Grussendorf E; Grussendorf J; White K; Bulaj KK; Krumin RK; Hunt M; Wilcox KS
Neurochem Res; 2017 Jul; 42(7):1995-2010. PubMed ID: 28508174
[TBL] [Abstract][Full Text] [Related]
19. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.
Samuels BA; Mendez-David I; Faye C; David SA; Pierz KA; Gardier AM; Hen R; David DJ
Neuroscientist; 2016 Feb; 22(1):26-45. PubMed ID: 25488850
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights.
Kremer M; Salvat E; Muller A; Yalcin I; Barrot M
Neuroscience; 2016 Dec; 338():183-206. PubMed ID: 27401055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
